Zealand Pharma news
Read verified news on BetaVoices covering Zealand Pharma, with reporting, context, and related developments.
#Zealand Pharma
Clear filters
Obesity drugs
Zealand Pharma’s stock swings show weight-loss drug market’s new test
Survodutide’s dropout rates cooled enthusiasm, but investors are watching whether amylin-based petrelintide can offer a more tolerable obesity treatment
Experimental obesity drugs
Safety questions grow around experimental weight-loss drugs
CBS News reported concerns over doctors prescribing retatrutide before FDA approval, while separate trial data for Zealand Pharma’s survodutide rattled investors over side effects
Obesity drugs
Zealand Pharma shares tumble as safety data hit drug hopes
Survodutide met late-stage trial goals, but gastrointestinal side effects and a 19% dropout rate raised doubts about its commercial potential
Page 1 of 1